Skip to main content
KWR $170.72 -0.41%
KWR logo

KWR · Quaker Chemical Corp

Track KWR — free
$170.72 -0.71 (-0.41%) At close · Aug 14
Market Cap
$2.95B
Shares
17.21M
All earnings calls

Earnings call · FY2025 Q4

Quaker Chemical Corp Q4 FY2025 Earnings Call

Quaker Chemical Corp Q4 FY2025 Earnings Call

Concluded Feb 24, 2026 Audio replay
Feb 24, 2026 48:22 49 turns
Period
FY2025 Q4
Runtime
48:22
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Quaker Houghton reported Q4 2025 net sales of $468.5 million, up 6% year-over-year, with adjusted EBITDA up 11% and non-GAAP EPS up 24%, driven by acquisitions and continued organic volume growth in Asia Pacific despite soft markets in the Americas and EMEA.

Asia Pacific Growth Momentum 35 Acquisitions and M&A Pipeline 26 Operational Disruptions in Q4 11 EBITDA Margin Expansion Target 10 Cash Flow and Balance Sheet 9 Cost Savings and Restructuring Initiatives 7

Management tone

Positive

Net tone +25 · moderate hedging

Grounding quotes
  • “Net share gains of approximately 4% mitigated the soft market and collective headwinds we experienced in the quarter, and we achieved slight organic volume growth for the full year.”
  • “Market conditions in the Americas and EMEA remain soft as uncertainty from tariffs and extended customer outages in North America and seasonal impacts affected us in the fourth quarter.”
  • “Our results were driven by new business wins in all regions highlighted by strong organic volume growth in the Asia Pacific region, where our planned strategic efforts continue to deliver consistently strong results.”
  • “We believe total company organic sales volumes would have been flat to the prior year in Q4 when adjusting for these factors.”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $468.48M +5.5% YoY
Gross margin · derived Q4 35.3% +0.1 pp YoY
Net income · derived Q4 $20.70M +45.9% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Q4 adjusted EBITDA up 11% Y/Y to $71.9 million, the second consecutive quarter of Y/Y EBITDA improvement
  • Q4 non-GAAP EPS of $1.65, up 24% Y/Y
  • Asia Pacific organic volume grew 4% in Q4, the 10th consecutive quarter of Y/Y volume growth, with full-year Asia Pacific net sales up 13%
  • Net share gains of approximately 4% globally in Q4
  • Three acquisitions completed in 2025, adding ~$95 million of annualized revenue; Dipsol contributed $21 million in Q4
  • Complexity and cost reduction plan generated ~$25 million of run-rate savings in 2025; announced Dortmund plant closure with ~$5 million annual savings starting 2027

Risks & pressure points

  • Total organic sales volumes declined less than 1% Y/Y in Q4, with declines in the Americas and EMEA due to soft markets, tariff uncertainty, an extended customer outage, and weather-related operational challenges in December
  • Full-year GAAP results include an $88.8 million impairment charge and $35.1 million of restructuring charges, resulting in a full-year net loss of $2.5 million and a loss per diluted share of $0.14
  • Full-year operating cash flow declined to $136 million from $205 million in 2024, driven by higher restructuring costs and negative working capital impacts
  • Q4 operating cash flow of $47 million was down from $63 million in the prior-year period
  • Full-year non-GAAP EPS of $7.02 declined from $7.44 in 2024, and full-year adjusted EBITDA of $299.2 million was down from $310.9 million in 2024
  • Gross margin in Q4 was down 150 basis points sequentially due to negative absorption and higher maintenance, repairs, and raw material disposal costs in North America

Key moments

Jump directly to management's words in the synchronized transcript.

“We anticipate underlying markets to remain flat in 2026 and with the potential for some incremental growth in the second half of the year. We remain confident in our ability to deliver net share gains within our target range of 2% to 4% as we execute our sales pipeline, benefit from the wrap of new business wins gained in 2025 and gain the full-year impact of acquisitions, primarily Dipsol in our results.” Speaker 2, CEO

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Buybacks · derived
$5.03M
Dividend / share
$0.51
Full-screen source Call document